Examining product risk in context: the case of zomepirac.
Spielberg
T E
TE
D000707:Anaphylaxis / Q000139:chemically induced; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D017277:Drug Approval; D006801:Humans; D011358:Product Surveillance, Postmarketing; D014046:Tolmetin / Q000009:adverse effects / Q000031:analogs & derivatives*
D000894:Anti-Inflammatory Agents, Non-Steroidal; C020549:zomepirac; D014046:Tolmetin